Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1967 2
1968 2
1969 2
1970 22
1971 8
1972 6
1973 12
1974 18
1975 40
1976 50
1977 45
1978 72
1979 85
1980 104
1981 96
1982 94
1983 106
1984 85
1985 90
1986 73
1987 88
1988 85
1989 79
1990 66
1991 73
1992 68
1993 46
1994 42
1995 54
1996 29
1997 48
1998 40
1999 39
2000 38
2001 23
2002 22
2003 22
2004 19
2005 19
2006 15
2007 11
2008 15
2009 16
2010 14
2011 13
2012 21
2013 9
2014 6
2015 11
2016 8
2017 19
2018 18
2019 15
2020 9
2021 5
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

2,101 results
Results by year
Filters applied: . Clear all
Page 1
Disopyramide.
Morady F, Scheinman MM, Desai J. Morady F, et al. Ann Intern Med. 1982 Mar;96(3):337-43. doi: 10.7326/0003-4819-96-3-337. Ann Intern Med. 1982. PMID: 7036817 Review.
Since disopyramide was introduced 5 years ago, the therapeutic spectrum of this drug in treating patients with ventricular and atrial arrhythmias has been found to be similar to that of the other type I antiarrhythmic drugs, quinidine and procainamide. Disopyramide
Since disopyramide was introduced 5 years ago, the therapeutic spectrum of this drug in treating patients with ventricular and atrial …
Disopyramide.
Vaughan Williams EM. Vaughan Williams EM. Ann N Y Acad Sci. 1984;432:189-200. doi: 10.1111/j.1749-6632.1984.tb14520.x. Ann N Y Acad Sci. 1984. PMID: 6395761 Review. No abstract available.
Disopyramide.
Koch-Weser J. Koch-Weser J. N Engl J Med. 1979 Apr 26;300(17):957-62. doi: 10.1056/NEJM197904263001705. N Engl J Med. 1979. PMID: 431563 No abstract available.
Disopyramide--a review.
Ankier SI, Carmichael DJ, Kidner PH. Ankier SI, et al. Scott Med J. 1977 Oct;22(4):314-9. doi: 10.1177/003693307702200424. Scott Med J. 1977. PMID: 337485 Review. No abstract available.
Clinical pharmacokinetics of disopyramide.
Siddoway LA, Woosley RL. Siddoway LA, et al. Clin Pharmacokinet. 1986 May-Jun;11(3):214-22. doi: 10.2165/00003088-198611030-00003. Clin Pharmacokinet. 1986. PMID: 3524956 Review.
Disopyramide is an antiarrhythmic agent with proven efficacy in the management of atrial and ventricular arrhythmias. ...Because the pharmacological effects of disopyramide are determined by unbound drug, changes in the unbound fraction could make total disopyram
Disopyramide is an antiarrhythmic agent with proven efficacy in the management of atrial and ventricular arrhythmias. ...Because the
Procainamide and disopyramide.
Ribeiro C, Longo A. Ribeiro C, et al. Eur Heart J. 1987 Mar;8 Suppl A:11-9. doi: 10.1093/eurheartj/8.suppl_a.11. Eur Heart J. 1987. PMID: 3556173 Review. No abstract available.
Disopyramide: clinical indications, pharmacokinetics and laboratory assessment.
Taylor EH, Pappas AA. Taylor EH, et al. Ann Clin Lab Sci. 1986 Jul-Aug;16(4):289-95. Ann Clin Lab Sci. 1986. PMID: 2427003 Review.
Disopyramide is metabolized to N-desisopropyl disopyramide in the liver with approximately 50 percent of the parent drug excreted unchanged. ...A method for performing both total and free disopyramide determinations is also described....
Disopyramide is metabolized to N-desisopropyl disopyramide in the liver with approximately 50 percent of the parent drug excre
Disopyramide: six years' experience.
Wilson RR, Wallace AG. Wilson RR, et al. Angiology. 1983 Jun;34(6):367-74. doi: 10.1177/000331978303400601. Angiology. 1983. PMID: 6346959 Review.
Since its approval by the FDA six years ago, oral disopyramide has earned a recognized role in the treatment of ventricular arrhythmias. ...This review explores the recent therapeutic experience with disopyramide....
Since its approval by the FDA six years ago, oral disopyramide has earned a recognized role in the treatment of ventricular arrhythmi …
Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug.
Verlinden NJ, Coons JC. Verlinden NJ, et al. Pharmacotherapy. 2015 Dec;35(12):1164-72. doi: 10.1002/phar.1664. Pharmacotherapy. 2015. PMID: 26684556 Review.
The pharmacologic rationale for use of disopyramide is largely based on its strong negative inotropic property. Three clinical studies have showed significant improvements in heart failure symptoms and a reduction in the need for invasive therapy in patients treated with …
The pharmacologic rationale for use of disopyramide is largely based on its strong negative inotropic property. Three clinical studie …
Disopyramide dialysability.
[No authors listed] [No authors listed] Lancet. 1978 Jul 22;2(8082):214. Lancet. 1978. PMID: 78419 No abstract available.
2,101 results